Company intelligence / Profile preview

Tenomix

London, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Early collaborations with leading hospitals in the US and Canada; completed a year-long clinical engagement; currently transitioning from prototype to pre-production commercial device. No human clinical trials or regulatory approval yet; initial results indicate streamlined workflow, increased lymph node identification, and consistent tissue analysis in pathology labs.

Therapeutic areas: Oncology
Modalities: DeviceArtificial intelligenceRoboticsUltrasound imaging
Industry: Pathology

Partnerships

Collaborations with leading US hospital(s) (unnamed)Collaborations with several top Canadian hospitalsSupported by University of Waterloo’s Velocity incubatorStrategic partnerships with research institutions

Beyond the preview

Go deeper on Tenomix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tenomix.

Explore the full profile